Primary results of the Spanish Cryoballoon Ablation Registry: acute and long-term outcomes of the RECABA study.

ABSTRACT: Cryoablation is safe and effective for the treatment of atrial fibrillation (AF) in controlled clinical trials, but contemporary real-world usage and outcomes are limited. The Report of the Spanish Cryoballoon Ablation Registry (RECABA) was designed to evaluate acute and 12-month outcomes of cryoballoon ablation for the treatment of AF in Spain. Patients from 27 Spanish centers were prospectively enrolled. Patients were treated with cryoballoon ablation and managed according to standard of care protocols at each center. The primary endpoint was ≥ 30 s freedom from AF at 12-month after a 3-month blanking period. Secondary endpoints included a description of patient characteristics, cryoablation procedural strategy and safety, and predictors of efficacy. In total, 1742 patients (71.4% PAF, 6

SUBMITTER: Ferrero-De-Loma-Osorio A 

PROVIDER: S-EPMC8390492 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature